The transcription factor NF-B regulates expression of genes that are involved in inflammation, immune response, viral infection, cell survival, and division. However, the role of NF-B in hypertrophic growth of terminally differentiated cardiomyocytes is unknown. Here we report that NF-B activation is required for hypertrophic growth of cardiomyocytes. In cultured rat primary neonatal ventricular cardiomyocytes, the nuclear translocation of NF-B and its transcriptional activity were stimulated by several hypertrophic agonists, including phenylephrine, endothelin-1, and angiotensin II. The activation of NF-B was inhibited by expression of a ''supersuppressor'' I B␣ mutant that is resistant to stimulationinduced degradation and a dominant negative I B kinase (IKK) mutant that can no longer be activated by phosphorylation. Furthermore, treatment with phenylephrine induced I B␣ degradation in an IKK-dependent manner, suggesting that NF-B is a downstream target of the hypertrophic agonists. Importantly, expression of the supersuppressor I B␣ mutant or the dominant negative IKK mutant blocked the hypertrophic agonist-induced expression of the embryonic gene atrial natriuretic factor and enlargement of cardiomyocytes. Conversely, overexpression of NF-B itself induced atrial natriuretic factor expression and cardiomyocyte enlargement. These findings suggest that NF-B plays a critical role in the hypertrophic growth of cardiomyocytes and may serve as a potential target for the intervention of heart disease.